Accretion Pha.

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0T8T01010
  • NSEID: ACCPL
  • BSEID:
INR
208.00
-2 (-0.95%)
BSENSE

Sep 21, 03:30 PM

BSE+NSE Vol: 38400

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 56.21% vs 329.70% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 26.03% vs 363.55% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -39.45% vs 259.94% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 42.31% vs 355.08% in Mar 2025

Compare Profit and Loss Results of Accretion Pha.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
89.00
105.00
-16.00
-15.24%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
10.00
-10.00
-100.00%
Net Sales
89.00
94.00
-5.00
-5.32%
Expenditure (Ex Depriciation)
Stock Adjustments
-4.00
0.00
-4.00
0%
Raw Materials Consumed
69.00
67.00
2.00
2.99%
Power & Fuel Cost
0.00
3.00
-3.00
-100.00%
Employee Cost
4.00
6.00
-2.00
-33.33%
Operating Expenses
1.00
1.00
0.00
0.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
2.00
-2.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
1.00
-1.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
74.00
84.00
-10.00
-11.90%
Operating Profit (PBDIT) excl Other Income
14.00
10.00
4.00
40.00%
Other Income
0.00
9.00
-9.00
-100.00%
Operating Profit (PBDIT)
15.00
19.00
-4.00
-21.05%
Interest
0.00
1.00
-1.00
-100.00%
Profit before Depriciation and Tax
14.00
17.00
-3.00
-17.65%
Depreciation
1.00
0.00
1.00
0%
Profit Before Taxation & Exceptional Items
13.00
17.00
-4.00
-23.53%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
13.00
17.00
-4.00
-23.53%
Provision for Tax
3.00
3.00
0.00
0.00%
Profit After Tax
9.00
14.00
-5.00
-35.71%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
7.00
40.00
-33.00
-82.50%
Profit Available for appropriations
16.00
54.00
-38.00
-70.37%
Appropriations
16.00
54.00
-38.00
-70.37%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
9.03
0.617
8.41
1,363.53%
Profit And Loss - Net Sales
Net Sales 89.63 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 56.21% vs 329.70% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 14.97 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 26.03% vs 363.55% in Mar 2025

Profit And Loss - Interest
Interest 0.87 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -39.45% vs 259.94% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 9.67 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 42.31% vs 355.08% in Mar 2025